Gynostemma pentaphyllum for dyslipidemia: A systematic review of randomized controlled trials

Objective: To evaluate the lipid-lowering effect and safety of Gynostemma pentaphyllum (GP) used alone or as adjunctive therapy for dyslipidemia. Methods: Eight databases and three clinical trial registries were searched until January 2022. Randomized controlled trials (RCTs) assessing the effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Ning, Zhao, Fang-fang, Fang, Min, Pu, Feng-lan, Kong, Ling-yao, Liu, Jian-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459123/
https://www.ncbi.nlm.nih.gov/pubmed/36091752
http://dx.doi.org/10.3389/fphar.2022.917521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459123/
https://www.ncbi.nlm.nih.gov/pubmed/36091752
http://dx.doi.org/10.3389/fphar.2022.917521

Ejemplares similares